Synthetic Lethality Screens Using RNAi in Combination with CRISPR-based Knockout in Drosophila Cells

Benjamin E Housden1, Hilary E Nicholson1,2, Norbert Perrimon1,3

  • 1Harvard Medical School, Boston, USA.

Bio-Protocol
|May 20, 2017
PubMed

Insights

Researchers developed a new high-throughput method combining CRISPR and RNAi for gene disruption. This approach identifies synthetic lethal interactions, crucial for understanding disease networks and finding cancer drug targets.

Area of Science:

  • Genetics and Genomics
  • Molecular Biology
  • Systems Biology

Background:

  • Synthetic lethal interactions occur when disrupting two genes together is lethal, unlike disrupting them individually.
  • Understanding these interactions aids in mapping biological networks and identifying potential therapeutic targets for diseases like cancer.
  • Previous methods in Drosophila used multiple RNAi reagents for combinatorial gene disruption.

Purpose of the Study:

  • To describe a novel protocol for high-throughput combinatorial gene disruption.
  • To leverage the CRISPR and RNAi systems for efficient gene targeting.
  • To identify reproducible and conserved synthetic lethal interactions.

Main Methods:

  • Development of a protocol integrating CRISPR and RNAi technologies.
  • Application of the combined CRISPR-RNAi system for high-throughput genetic screening.
  • Utilizing Drosophila as a model organism for experimental validation.

Main Results:

  • Successful implementation of a high-throughput combinatorial gene disruption strategy.
  • Identification of numerous synthetic lethal interactions with high reproducibility.
  • Demonstration of conserved synthetic lethal interactions across species.

Conclusions:

  • The combined CRISPR-RNAi approach offers a powerful tool for discovering synthetic lethal interactions.
  • This method facilitates the elucidation of complex genetic networks.
  • The identified interactions represent promising candidates for cancer drug development.